All posts
-
Saronic wins contract for Corsair Autonomous Surface Vessel production
Revealed by Assistant of the Navy John. C Phelan on December 8th, Saronic, a Texas based self-governing vessel producer has actually racked up a numerous hundred million buck agree…
-
GE Aerospace secures orders for LM2500 to power Flight III destroyers
GE Aerospace’s Marine Engines & Equipment has actually gotten orders to provide 8 LM2500 aquatic gas generator engines for the united state Navy’s following 2 Trip…
-
AUKUS: HII Hosts Australian Delegation at Newport News Shipbuilding
HII hosted an Australian delegation led by Richard Marles MP, deputy prime minister and minister for defence, at its Newport News Shipbuilding division Tuesday. HII press release T…
-
Genmab completes acquisition of Dutch biotech company Merus
The procurement was revealed back in September and can currently be settled.
-
Zealand Pharma to quintuple research costs as part of new strategy
The Danish business is likewise readied to obtain a significant settlement following year as an outcome of its contract with Swiss business Roche, according to CFO.
-
Shareholders hope for a clear strategy before meeting Bavarian Nordic management
A number of investors likewise really hope that the firm will certainly attend to the make-up of its board of supervisors. They claim that there is an absence of competence after t…
-
Zealand Pharma ready with new strategy: Aims to lead in obesity and metabolic disorders
The method will certainly exist at the business’s funding markets day, which occurs on Thursday.
-
“A step in the wrong direction:” Industry fears consequences of new EU pharma package
The Confederation of Danish Sector and the Danish Chamber of Business both keep that the life scientific research sector is currently in an even worse setting in Europe.
-
Eli Lilly rumored to be interested in acquiring promising French biotech company
The firm just recently provided favorable information from a stage III test of a medicine for the intestinal tract illness ulcerative colitis.
-
Hedge funds reap billions from biotech boom
The boom is driven by license spaces in big pharmaceutical business that do not think twice to take part in bidding process battles in the quest for the following large smash hit m…
